Literature DB >> 2344006

Abnormalities of carbohydrate metabolism and of OCT gene function in the Rett syndrome.

A Clarke1, D Gardner-Medwin, J Richardson, A McGann, J R Bonham, K H Carpenter, S Bhattacharya, D Haggerty, J A Fleetwood, A Aynsley-Green.   

Abstract

The pathogenetic basis of the Rett syndrome (RS) is unknown: an X-linked dominant, male-lethal gene defect is thought likely. We present a girl with RS who has defects both of the urea cycle and of carbohydrate metabolism resulting in fasting hypoglycaemia, post-prandial hyperlactataemia and excess urinary orotic acid excretion after alanine load. Her sister has a similar clinical picture, but less marked metabolic anomalies. The mother of these sisters has abnormal urinary orotic acid excretion; she transmitted opposite ornithine carbomoyltransferase (OCT) alleles to the two girls. Another girl with RS has similar metabolic responses to fasting and to carbohydrate load. We conclude that RS may be an aetiologically homogeneous condition, but that it includes a variable pattern of metabolic anomalies, and that the gene defect is distinct from the OCT locus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2344006     DOI: 10.1016/s0387-7604(12)80191-4

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  4 in total

Review 1.  Rett syndrome: a review of current knowledge.

Authors:  R Van Acker
Journal:  J Autism Dev Disord       Date:  1991-12

Review 2.  Rett syndrome.

Authors:  A Clarke
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

3.  the allopurinol test in patients with Rett syndrome.

Authors:  M Pineda; M A Vilaseca; A Vernet; J Campistol; A Mas; C Fabrega
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

4.  X chromosome linkage studies in familial Rett syndrome.

Authors:  A R Curtis; S Headland; S Lindsay; N S Thomas; E Boye; S Kamakari; P Roustan; M Anvret; J Wahlstrom; G McCarthy
Journal:  Hum Genet       Date:  1993-01       Impact factor: 4.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.